Onconetics Pharmaceuticals, Inc.

Engineering the Future of Gene Therapy

A Gene Therapy Platform for Curing Cancer

Cancer is caused by malfunctions in the cell’s regulatory machinery leading to uncontrolled cell growth.  At Onconetics, we use these regulatory differences to target the expression of a kill gene to attack cancer from within.

By harnessing the cell’s regulatory network of a cell, Onconetics’ therapeutic approach facilitates the highly specific targeting of cancer cells in order to mitigate side effects and enhance the quality of life for patients.


Onconetics is engaged with global organizations and leaders who share our vision.


Learn more about the conception of the Onconetics, and the inspiration of the founders


Meet our team of world leaders in gene therapy research, global health policy and business

Keep in touch with us!